Human CD69/CLEC2C ORF/cDNA clone-Adenovirus particle (BC007037)
Cat. No.: vGMAP000449
Pre-made Human CD69/CLEC2C Adenovirus for CD69 overexpression in-vitro and in-vivo. The CD69 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified CD69-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
CD69/CLEC2C products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP000449 | Human CD69 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP000449 |
| Gene Name | CD69 |
| Accession Number | BC007037 |
| Gene ID | 969 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 600 bp |
| Gene Alias | CLEC2C |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAGCTCTGAAAATTGTTTCGTAGCAGAGAACAGCTCTTTGCATCCGGAGAGTGGACAAGAAAATGATGCCACCAGTCCCCATTTCTCAACACGTCATGAAGGGTCCTTCCAAGTTCCTGTCCTGTGTGCTGTAATGAATGTGGTCTTCATCACCATTTTAATCATAGCTCTCATTGCCTTATCAGTGGGCCAATACAATTGTCCAGGCCAATACACATTCTCAATGCCATCAGACAGCCATGTTTCTTCATGCTCTGAGGACTGGGTTGGCTACCAGAGGAAATGCTACTTTATTTCTACTGTGAAGAGGAGCTGGACTTCAGCCCAAAATGCTTGTTCTGAACATGGTGCTACTCTTGCTGTCATTGATTCTGAAAAGGACATGAACTTTCTAAAACGATACGCAGGTAGAGAGGAACACTGGGTTGGACTGAAAAAGGAACCTGGTCACCCATGGAAGTGGTCAAATGGCAAAGAATTTAACAACTGGTTCAACGTTACAGGGTCTGACAAGTGTGTTTTTCTGAAAAACACAGAGGTCAGCAGCATGGAATGTGAGAAGAATTTATACTGGATATGTAACAAACCTTACAAATAA |
| ORF Protein Sequence | MSSENCFVAENSSLHPESGQENDATSPHFSTRHEGSFQVPVLCAVMNVVFITILIIALIALSVGQYNCPGQYTFSMPSDSHVSSCSEDWVGYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGREEHWVGLKKEPGHPWKWSNGKEFNNWFNVTGSDKCVFLKNTEVSSMECEKNLYWICNKPYK |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-IP0188-Ab | Anti-CD69 monoclonal antibody |
| Target Antigen | GM-Tg-g-IP0188-Ag | CD69 protein |
| ORF Viral Vector | pGMLP000408 | Human CD69 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000449 | Human CD69 Adenovirus plasmid |
| ORF Viral Vector | vGMLP000408 | Human CD69 Lentivirus particle |
| ORF Viral Vector | vGMAP000449 | Human CD69 Adenovirus particle |
Target information
| Target ID | GM-IP0188 |
| Target Name | CD69 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
969 |
| Gene ID |
100053615 (Equus caballus), 101082498 (Felis catus), 281058 (Bos taurus), 29187 (Rattus norvegicus) 477698 (Canis lupus familiaris), 717288 (Macaca mulatta), 969 (Homo sapiens) |
| Gene Symbols & Synonyms | CD69,Cd69,AIM,EA1,MLR-3,CLEC2C,GP32/28,BL-AC/P26 |
| Target Alternative Names | AIM,Activation inducer molecule (AIM),BL-AC/P26,C-type lectin domain family 2 member C,CD69,CLEC2C,Cd69,EA1,Early T-cell activation antigen p60,Early activation antigen CD69,GP32/28,Leukocyte surface antigen Leu-23,MLR-3 |
| Uniprot Accession |
Q07108
Additional SwissProt Accessions: Q07108 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | |
| Disease | cancer |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000023027, ENSBTAG00000002135, ENSCAFG00845027879, ENSMMUG00000015297, ENSG00000110848 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


